Amneal launched record number of 39 new retail and injectable products in 2023, including 13 in q4 2023

Bridgewater, n.j.--(business wire)--amneal pharmaceuticals, inc. (nasdaq: amrx) (“amneal”) today announces that it has launched 39 new retail and injectable medicines in 2023, as compared to 26 new launches in 2022. in the fourth quarter of 2023, amneal launched 13 new products, including 5 injectables. new injectable products added include potassium phosphate vials, tranexamic acid and esmolol intravenous bags. these launches provide a strong foundation for higher injectable revenues going for.
AMRX Ratings Summary
AMRX Quant Ranking